A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2011
10/04/2011	US8030459 Oxime conjugates and methods for their formation and use
10/04/2011	US8030361 Cell culture carrier implantable in vivo
10/04/2011	US8030313 Controlled release sterile injectable aripiprazole formulation and method
10/04/2011	US8030297 Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
10/04/2011	US8030285 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent
10/04/2011	US8030269 Calcitonin drug-oligomer conjugates, and uses thereof
10/04/2011	US8029823 Controlled release and taste masking oral pharmaceutical composition
10/04/2011	US8029821 Capsule comprising low-substituted cellulose ether and method for preparing the same
10/04/2011	US8029820 Patches containing tulobuterol
10/04/2011	US8029819 Pet food includes 35-70% by weight protein, 4-10% by weight fat, 5-25% by weight fiber, 10-35% by weight digestible carbohydrate, 0.1-1% by weight functional ingredient to build lean muscle mass
10/04/2011	US8029810 Water-based delivery systems
10/04/2011	US8029798 Multivalent vaccine composition with mixed carrier
10/04/2011	US8029789 Method for the mass production of immunoglobulin constant region
10/04/2011	US8029781 Methods of treating a deficiency of functional tripeptidyl peptidase I (CLN2) protein
10/04/2011	US8029776 Cationic lipid-mediated enhancement of nucleic acid immunization of cats
10/04/2011	US8029774 Wound healing polymeric networks
10/04/2011	US8029768 pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
10/04/2011	US8029609 Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid
10/04/2011	CA2673462C Solid oral dosage forms of valsartan
10/04/2011	CA2532755C Veterinary aqueous injectable suspensions containing florfenicol
10/04/2011	CA2488915C Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
10/04/2011	CA2481770C Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis
10/04/2011	CA2467828C Pharmaceutical formulations comprising an immune response modifier
10/04/2011	CA2440394C Biodegradable copolymers linked to segment with a plurality of functional groups
10/04/2011	CA2436686C Process for decreasing the reducing sugars content of light steepwater
10/04/2011	CA2381123C Actinium-225 complexes and conjugates for radioimmunotherapy
09/2011
09/30/2011	CA2735513A1 Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
09/29/2011	WO2011120053A1 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
09/29/2011	WO2011119995A2 Formulations and methods of use
09/29/2011	WO2011119988A1 Methods of treatment of hepatocellular carcinoma
09/29/2011	WO2011119487A2 Compositions and methods useful for stabilizing protein-containing formulations
09/29/2011	WO2011119477A2 Pharmaceutical compositions of carvedilol salts and process for preparation thereof
09/29/2011	WO2011119288A2 Multilayer melt-extruded film
09/29/2011	WO2011119126A1 Use of oxalic acid in the production of a therapeutic preparation with anti-tumour activity in relation to malignant cells, a therapeutic preparation based thereon and a method of treatment
09/29/2011	WO2011119125A1 Use of lithium oxalate in production of a therapeutic preparation with anti-tumour activity in relation to malignant cells, a therapeutic preparation based thereon and a method of treatment
09/29/2011	WO2011119059A1 Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof
09/29/2011	WO2011118958A2 Oil-in-water type nano-emulsion composition and method for preparing same
09/29/2011	WO2011118810A1 Nutritional composition
09/29/2011	WO2011118683A1 Patch for medical use
09/29/2011	WO2011118604A1 Hydrous adhesive patch
09/29/2011	WO2011118481A1 Method for reducing unpleasant taste
09/29/2011	WO2011118453A1 Solid preparation
09/29/2011	WO2011117851A1 Transdermal administration of peptides
09/29/2011	WO2011117711A1 Pharmaceutical composition comprising a pyrimidineone derivative
09/29/2011	WO2011117389A1 Antimicrobial oil-in-water emulsion
09/29/2011	WO2011116908A1 Pharmaceutical composition containing cyclodextrin copolymer
09/29/2011	WO2011091322A3 Antimicrobial agent comprising peroxide, alcohol and chelating agent
09/29/2011	WO2011062936A3 Self-assembled toroidal-spiral particles and manufacture and uses thereof
09/29/2011	WO2011057266A3 Emulsion template method to form small particles of hydrophobic agents with surface enriched hydrophilicity by ultra rapid freezing
09/29/2011	WO2011056785A3 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
09/29/2011	WO2011056325A3 Oligomer-calcimimetic conjugates and related compounds
09/29/2011	WO2011026125A3 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
09/29/2011	WO2010119364A3 A medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same
09/29/2011	US20110238000 Polymer-conjugated albumin hydrogels for controlled release of therapeutic agents
09/29/2011	US20110237811 Stabilized steroid composition and method for its preparation
09/29/2011	US20110237747 Multi-Arm Polypeptide-Poly(ethylene glycol) Block Copolymers as Drug Delivery Vehicles
09/29/2011	US20110237746 Method Involving 1-Benzotriazolyl Carbonate Esters of Polymers
09/29/2011	US20110237687 Adjusting drug loading in polymeric materials
09/29/2011	US20110237686 Formulations and methods of use
09/29/2011	US20110237623 Sustained-release donepezil formulation
09/29/2011	US20110237552 Composite Material Consisting of a Collagen Matrix Mineralised with Silicate and Calcium Phosphate Phases, Method for the Production and Use Thereof
09/29/2011	US20110237546 Method for treating a mammal by administration of a compound having the ability to release co
09/29/2011	US20110237504 Delivery agents for enhancing mucosal absorption of therapeutic agents
09/29/2011	US20110236497 Compositions and Methods for Improved Retention of a Pharmaceutical Composition at a Local Administration Site
09/29/2011	US20110236492 Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
09/29/2011	US20110236485 Shell and core dosage form approaching zero-order drug release
09/29/2011	US20110236479 Direct compression formulation and process
09/29/2011	US20110236458 Coating
09/29/2011	US20110236454 Injectable drug delivery formulation
09/29/2011	US20110236450 Polyelectrolyte complexes
09/29/2011	US20110236443 Multilayer melt-extruded film
09/29/2011	US20110236308 Aryl Bidentate Isonitriles and Their Uses
09/29/2011	DE19724456B4 Medizinische Mischungszusammensetzung mit lang anhaltender Arzneimittelabgabemöglichkeit Medical mixture composition with sustained drug delivery option
09/29/2011	CA2794540A1 Methods and compositions for weight loss
09/29/2011	CA2794307A1 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
09/29/2011	CA2793973A1 Pharmaceutical compositions of carvedilol salts and process for preparation thereof
09/29/2011	CA2793536A1 Methods of treatment of hepatocellular carcinoma
09/29/2011	CA2792913A1 Improved stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone
09/29/2011	CA2792470A1 Transdermal administration of peptides
09/29/2011	CA2792136A1 Reverse micelle system comprising metal ions and use thereof
09/29/2011	CA2792125A1 Compositions and methods useful for stabilizing protein-containing formulations
09/29/2011	CA2789900A1 Pharmaceutical composition comprising a pyrimidineone derivative
09/29/2011	CA2789075A1 Solid preparation
09/28/2011	EP2369345A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
09/28/2011	EP2369005A1 Biological active proteins having increased in vivo and/or in vitro stability
09/28/2011	EP2368899A1 Avian influenza vaccine
09/28/2011	EP2368579A1 Transglutaminase mediated conjugation of peptides
09/28/2011	EP2368554A1 Pharmaceutical formulations containing methylnaltrexone
09/28/2011	EP2368553A1 Pharmaceutical formulations containing methylnaltrexone
09/28/2011	EP2368548A1 Dry powder pharmaceutical composition for inhalation
09/28/2011	EP2368546A2 Pharmaceutical composition for the controlled release of methylphenidate
09/28/2011	EP2368544A1 Orally rapidly disintegrating tablet, and process for producing same
09/28/2011	EP2368445A1 Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same
09/28/2011	EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides
09/28/2011	EP2367573A1 Liquid pharmaceutical compositions comprising a triptan compound and xylitol
09/28/2011	EP2367572A2 Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
09/28/2011	EP2367567A1 Antigen-presenting scaffolds
09/28/2011	EP2367541A1 Misuse preventative, controlled release formulation
09/28/2011	EP2367539A1 Novel composition for treatment of essential thrombocythemia
09/28/2011	EP2367422A1 Enema formulations

1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 1712